279 related articles for article (PubMed ID: 10994727)
21. Pelvic lymph node dissection in metastatic melanoma to the groin should not be abandoned yet.
Faut M; Kruijff S; Hoekstra HJ; van Ginkel RJ; Been LB; van Leeuwen BL
Eur J Surg Oncol; 2018 Nov; 44(11):1779-1785. PubMed ID: 30054111
[TBL] [Abstract][Full Text] [Related]
22. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer.
Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A
Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793
[TBL] [Abstract][Full Text] [Related]
23. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
Williams AD; Cousins C; Soutter WP; Mubashar M; Peters AM; Dina R; Fuchsel F; McIndoe GA; deSouza NM
AJR Am J Roentgenol; 2001 Aug; 177(2):343-8. PubMed ID: 11461859
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ
Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
[TBL] [Abstract][Full Text] [Related]
25. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma.
Kamath D; Rapaport D; DeConti R; Cruse CW; Wells K; Glass F; Messina J; Fenske N; Brobeil A; Berman C; Puleo C; Reintgen D
J Fla Med Assoc; 1997 Mar; 84(3):182-7. PubMed ID: 9143170
[TBL] [Abstract][Full Text] [Related]
26. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
27. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy.
Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J
J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467
[TBL] [Abstract][Full Text] [Related]
28. Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
Chang CH; Wu HC; Tsai JJ; Shen YY; Changlai SP; Kao A
Urol Int; 2003; 70(4):311-5. PubMed ID: 12740497
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with extramammary Paget's disease.
Fujiwara M; Suzuki T; Senoo A; Fukamizu H; Tokura Y
J Dermatol; 2017 Aug; 44(8):939-943. PubMed ID: 28295555
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis of sentinel lymph node in malignant melanoma: preoperative lymphoscintigraphy and intraoperative gamma probe guidance].
Dresel S; Weiss M; Heckmann M; Rossmüller B; Konz B; Tatsch K; Hahn K
Nuklearmedizin; 1998 Aug; 37(5):177-82. PubMed ID: 9728345
[TBL] [Abstract][Full Text] [Related]
31. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
[TBL] [Abstract][Full Text] [Related]
32. FDG PET in early stage cutaneous malignant melanoma.
McIvor J; Siew T; Campbell A; McCarthy M
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
[TBL] [Abstract][Full Text] [Related]
33. Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.
Adler LP; Faulhaber PF; Schnur KC; Al-Kasi NL; Shenk RR
Radiology; 1997 May; 203(2):323-7. PubMed ID: 9114082
[TBL] [Abstract][Full Text] [Related]
34. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.
Reinhardt MJ; Ehritt-Braun C; Vogelgesang D; Ihling C; Högerle S; Mix M; Moser E; Krause TM
Radiology; 2001 Mar; 218(3):776-82. PubMed ID: 11230656
[TBL] [Abstract][Full Text] [Related]
35. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.
Yeh LS; Hung YC; Shen YY; Kao CH; Lin CC; Lee CC
Oncol Rep; 2002; 9(6):1289-92. PubMed ID: 12375036
[TBL] [Abstract][Full Text] [Related]
36. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma.
Brountzos EN; Panagiotou IE; Bafaloukos DI; Kelekis DA
Oncol Rep; 2003; 10(2):505-10. PubMed ID: 12579298
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy and predictive value of the tumor-associated antigen S100 in malignant melanomas: validation by whole body FDG-PET and conventional diagnostics.
Mruck S; Baum RP; Rinne D; Hör G
Anticancer Res; 1999; 19(4A):2685-90. PubMed ID: 10470220
[TBL] [Abstract][Full Text] [Related]
38. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancer.
Klar M; Meyer PT; Hancke K; Brink I; Orlowska-Volk M; Gitsch G; Denschlag D
Anticancer Res; 2010 Sep; 30(9):3787-90. PubMed ID: 20944170
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]